Human Molecular Genetics · 2016 · 100 citations · 50 references
Life SciencesMolecular BiologyNeuroscienceEndocytosisMolecular NeuroscienceNeurodegenerationAlzheimer DiseaseAmyloid FormationEndosomal TraffickingLate EndosomesNeurodegenerative DiseasesNeurodegenerative DisordersAlzheimer Disease Lysosomal PathologyAmyloid Beta AggregationAmyloid Beta PeptidesEndosomal Protein SortingLate Onset Alzheimer DiseaseLysosomal Degradation PathwaysSrc Homology 3 DomainsTransmembrane Proteins
BIN1 is a genetic risk factor of late-onset Alzheimer disease (AD), which was identified in multiple genome-wide association studies. BIN1 is a member of the amphiphysin family of proteins, and contains N-terminal Bin-Amphiphysin-Rvs and C-terminal Src homology 3 domains. BIN1 is widely expressed in the mouse and human brains, and has been reported to function in the endocytosis and the endosomal sorting of membrane proteins. BACE1 is a type 1 transmembrane aspartyl protease expressed predominantly in neurons of the brain and responsible for the production of amyloid-β peptide (Aβ). Here we report that the depletion of BIN1 increases cellular BACE1 levels through impaired endosomal trafficking and reduces BACE1 lysosomal degradation, resulting in increased Aβ production. Our findings provide a mechanistic role of BIN1 in the pathogenesis of AD as a novel genetic regulator of BACE1 levels and Aβ production.
50
Genome engineering using the CRISPR-Cas9 system
F. Ann Ran, Patrick D. Hsu, Jason Wright et al. · Nature Protocols · 2013 · 11.7K citations · Full text
Purification and cloning of amyloid precursor protein β-secretase from human brain
Sukanto Sinha, John P. Anderson, Robin Barbour et al. · Nature · 1999 · 1.6K citations
Membrane-anchored aspartyl protease with Alzheimer's disease β-secretase activity
Riqiang Yan, Michael J. Bienkowski, Mary E. Shuck et al. · Nature · 1999 · 1.4K citations